Godley P A, Ataga K I
University of North Carolina at Chapel Hill, Division of Hematology/Oncology and the Lineberger Comprehensive Cancer Center, Chapel Hill 27599-7305, USA.
Curr Opin Oncol. 2000 May;12(3):260-4. doi: 10.1097/00001622-200005000-00013.
The overall incidence of renal cell carcinoma is rising, for reasons not fully explained by increased abdominal imaging. Risk factors associated with renal cell carcinoma include hypertension, smoking, increased body mass index, and diet. There is an inverse association of renal cell carcinoma risk with consumption of a variety of carotenes. In addition, increased red meat intake has been associated with increased risk. Partial nephrectomy may be as effective as radical nephrectomy as treatment for localized disease, and radiosurgery may be as effective as surgical resection in the management of brain metastases. Immunotherapy remains the mainstay for systemic treatment, with response rates between 5% and 20%. Survival in renal cell carcinoma is related to pathologic stage, nuclear grade, microscopic vascular invasion, DNA content, nuclear morphometry, and histologic pattern. In addition, patients with deletion (8p)/-8, +12, and +20 appear to have a worse prognosis.
肾细胞癌的总体发病率正在上升,腹部影像学检查增多并不能完全解释其原因。与肾细胞癌相关的危险因素包括高血压、吸烟、体重指数增加和饮食。肾细胞癌风险与多种类胡萝卜素的摄入呈负相关。此外,红肉摄入量增加与风险升高有关。对于局限性疾病,部分肾切除术可能与根治性肾切除术一样有效,而立体定向放射外科治疗在脑转移瘤的管理中可能与手术切除一样有效。免疫疗法仍然是全身治疗的主要手段,有效率在5%至20%之间。肾细胞癌的生存率与病理分期、核分级、微小血管侵犯、DNA含量、核形态测量以及组织学模式有关。此外,存在8号染色体短臂缺失(8p)/-8、12号染色体三体(+12)和20号染色体三体(+20)的患者预后似乎更差。